PMID- 20150565 OWN - NLM STAT- MEDLINE DCOM- 20100812 LR - 20220408 IS - 1522-1601 (Electronic) IS - 8750-7587 (Print) IS - 0161-7567 (Linking) VI - 108 IP - 5 DP - 2010 May TI - Blood flow restriction exercise stimulates mTORC1 signaling and muscle protein synthesis in older men. PG - 1199-209 LID - 10.1152/japplphysiol.01266.2009 [doi] AB - The loss of skeletal muscle mass during aging, sarcopenia, increases the risk for falls and dependence. Resistance exercise (RE) is an effective rehabilitation technique that can improve muscle mass and strength; however, older individuals are resistant to the stimulation of muscle protein synthesis (MPS) with traditional high-intensity RE. Recently, a novel rehabilitation exercise method, low-intensity RE, combined with blood flow restriction (BFR), has been shown to stimulate mammalian target of rapamycin complex 1 (mTORC1) signaling and MPS in young men. We hypothesized that low-intensity RE with BFR would be able to activate mTORC1 signaling and stimulate MPS in older men. We measured MPS and mTORC1-associated signaling proteins in seven older men (age 70+/-2 yr) before and after exercise. Subjects were studied identically on two occasions: during BFR exercise [bilateral leg extension exercise at 20% of 1-repetition maximum (1-RM) with pressure cuff placed proximally on both thighs and inflated at 200 mmHg] and during exercise without the pressure cuff (Ctrl). MPS and phosphorylation of signaling proteins were determined on successive muscle biopsies by stable isotopic techniques and immunoblotting, respectively. MPS increased 56% from baseline after BFR exercise (P<0.05), while no change was observed in the Ctrl group (P>0.05). Downstream of mTORC1, ribosomal S6 kinase 1 (S6K1) phosphorylation and ribosomal protein S6 (rpS6) phosphorylation increased only in the BFR group after exercise (P<0.05). We conclude that low-intensity RE in combination with BFR enhances mTORC1 signaling and MPS in older men. BFR exercise is a novel intervention that may enhance muscle rehabilitation to counteract sarcopenia. FAU - Fry, Christopher S AU - Fry CS AD - University of Texas Medical Branch, Sealy Center on Aging, Department of Physical Therapy, Division of Rehabilitation Sciences, 301 Univ. Blvd., Galveston, TX 77555-1144, USA. FAU - Glynn, Erin L AU - Glynn EL FAU - Drummond, Micah J AU - Drummond MJ FAU - Timmerman, Kyle L AU - Timmerman KL FAU - Fujita, Satoshi AU - Fujita S FAU - Abe, Takashi AU - Abe T FAU - Dhanani, Shaheen AU - Dhanani S FAU - Volpi, Elena AU - Volpi E FAU - Rasmussen, Blake B AU - Rasmussen BB LA - eng GR - AR-049877/AR/NIAMS NIH HHS/United States GR - 1UL1RR029876-01/RR/NCRR NIH HHS/United States GR - T32-HD-07539/HD/NICHD NIH HHS/United States GR - R01 AR049877/AR/NIAMS NIH HHS/United States GR - P30-AG-024832/AG/NIA NIH HHS/United States GR - P30 AG024832/AG/NIA NIH HHS/United States PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20100211 PL - United States TA - J Appl Physiol (1985) JT - Journal of applied physiology (Bethesda, Md. : 1985) JID - 8502536 RN - 0 (Biomarkers) RN - 0 (Fibrin Fibrinogen Degradation Products) RN - 0 (Hormones) RN - 0 (Insulin) RN - 0 (Multiprotein Complexes) RN - 0 (Muscle Proteins) RN - 0 (Proteins) RN - 0 (Ribosomal Protein S6) RN - 0 (Transcription Factors) RN - 0 (fibrin fragment D) RN - EC 2.7.11.1 (Mechanistic Target of Rapamycin Complex 1) RN - EC 2.7.11.1 (Ribosomal Protein S6 Kinases, 70-kDa) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - EC 2.7.11.1 (ribosomal protein S6 kinase, 70kD, polypeptide 1) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinases) RN - S88TT14065 (Oxygen) SB - IM MH - Age Factors MH - Aged MH - Biomarkers/blood MH - Biopsy MH - Blotting, Western MH - Fibrin Fibrinogen Degradation Products/metabolism MH - Hormones/blood MH - Humans MH - Insulin/metabolism MH - Male MH - Mechanistic Target of Rapamycin Complex 1 MH - Mitogen-Activated Protein Kinases/metabolism MH - Multiprotein Complexes MH - *Muscle Contraction MH - Muscle Proteins/*biosynthesis/genetics MH - Organ Size MH - Oxygen/blood MH - Phosphorylation MH - Proteins MH - Quadriceps Muscle/anatomy & histology/*blood supply/*metabolism MH - Recovery of Function MH - Regional Blood Flow MH - *Resistance Training MH - Ribosomal Protein S6/metabolism MH - Ribosomal Protein S6 Kinases, 70-kDa/metabolism MH - Sex Factors MH - *Signal Transduction MH - TOR Serine-Threonine Kinases MH - Thrombosis/blood MH - Time Factors MH - Transcription Factors/*metabolism PMC - PMC2867530 EDAT- 2010/02/13 06:00 MHDA- 2010/08/13 06:00 PMCR- 2011/05/01 CRDT- 2010/02/13 06:00 PHST- 2010/02/13 06:00 [entrez] PHST- 2010/02/13 06:00 [pubmed] PHST- 2010/08/13 06:00 [medline] PHST- 2011/05/01 00:00 [pmc-release] AID - 01266.2009 [pii] AID - JAPPL-01266-2009 [pii] AID - 10.1152/japplphysiol.01266.2009 [doi] PST - ppublish SO - J Appl Physiol (1985). 2010 May;108(5):1199-209. doi: 10.1152/japplphysiol.01266.2009. Epub 2010 Feb 11.